PELP1: Structure, biological function and clinical significance

被引:35
|
作者
Sareddy, Gangadhara Reddy [1 ]
Vadlamudi, Ratna K. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA
基金
美国国家卫生研究院;
关键词
Nuclear receptor; Estrogen receptor; Transcriptional activation; Hormonal action; Signal transduction; Coregulator; PELP1; GLUTAMIC-ACID-RICH; RECEPTOR COACTIVATOR PELP1/MNAR; GROWTH-FACTOR REGULATION; ESTROGEN-RECEPTOR; BREAST-CANCER; ANDROGEN RECEPTOR; PROLINE-RICH; ONCOGENIC FUNCTIONS; PROGNOSTIC-SIGNIFICANCE; NONGENOMIC ACTIVITY;
D O I
10.1016/j.gene.2016.03.017
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Proline-, glutamic acid-, and leucine-rich protein 1 (PELP1) is a scaffolding protein that functions as a coregulator of several transcription factors and nuclear receptors. Notably, the PELP1 protein has a histone-binding domain, recognizes histone modifications and interacts with several chromatin-modifying complexes. PELP1 serves as a substrate of multitude of kinases, and phosphorylation regulates its functions in various complexes. Further, PELP1 plays essential roles in several pathways including hormonal signaling, cell cycle progression, ribosomal biogenesis, and the DNA damage response. PELP1 expression is upregulated in several cancers, its deregulation contributes to therapy resistance, and it is a prognostic biomarker for breast cancer survival. Recent evidence suggests that PELP1 represents a novel therapeutic target for many hormonal cancers. In this review, we summarized the emerging biological properties and functions of PELP1. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 50 条
  • [21] PELP1: a key mediator of oestrogen signalling and actions in the brain
    Thakkar, R.
    Sareddy, G. R.
    Zhang, Q.
    Wang, R.
    Vadlamudi, R. K.
    Brann, D.
    JOURNAL OF NEUROENDOCRINOLOGY, 2018, 30 (02)
  • [22] Regulation of rDNA Transcription by Proto-Oncogene PELP1
    Gonugunta, Vijay K.
    Nair, Binoj C.
    Rajhans, Rajib
    Sareddy, Gangadhara R.
    Nair, Sujit S.
    Vadlamudi, Ratna K.
    PLOS ONE, 2011, 6 (06):
  • [23] Regulation of mTOR Signaling by Proto-Oncogene PELP1
    Gonugunta, V. K.
    Cortez, V.
    Rethman, C.
    Nair, B. C.
    Sareddy, G. R.
    Vadlamudi, R. K.
    CANCER RESEARCH, 2011, 71
  • [24] Regulation of aromatase induction by nuclear receptor coregulator PELP1
    Vadlamudi, Ratna K.
    Rajhans, Rajib
    Chakravarty, Dimple
    Nair, Binoj C.
    Nair, Sujit S.
    Evans, Dean B.
    Chen, Shiuan
    Tekmal, Rajeshwar Rao
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 118 (4-5): : 211 - 218
  • [25] PELP1 - A novel estrogen receptor-interacting protein
    Brann, Darrell W.
    Zhang, Quan-Guang
    Wang, Rui-Min
    Mahesh, Virendra B.
    Vadlamudi, Ratna K.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 290 (1-2) : 2 - 7
  • [26] PELP1在胃癌中的致瘤作用
    颜洪竹
    孙燕玲
    吴喆
    孙元鹏
    刘于思
    韦先明
    马梓
    刘尚勤
    肖武汉
    宁志丰
    刘复兴
    华中科技大学学报(医学版), 2020, 49 (05) : 536 - 544
  • [27] PELP1: A novel therapeutic target for ovarian cancer progression and metastasis
    Chakravarty, Dimple
    Challa, Rambabu
    Dandamudi, Rajasekhar
    Vivas-Mejia, Pablo
    Lopez-Berestein, Gabriel
    Tekmal, Rajeshwar Rao
    Sood, Anil K.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2010, 70
  • [28] PELP1 is a novel reader of chromatin modifications: Implications in cancer progression
    Vadlamudi, Ratna K.
    Mann, Monica
    Cortez, Valerie A.
    CANCER RESEARCH, 2011, 71
  • [29] PELP1: A novel therapeutic target for ovarian cancer progression and metastasis
    Chakravarty, Dimple
    Challa, Rambabu
    Dandamudi, Rajasekhar
    Vivas-Mejia, Pablo
    Lopez-Berestein, Gabriel
    Tekmal, Rajeshwar Rao
    Sood, Anil K.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2010, 70
  • [30] PELP1 Oncogenic Functions Involve Regulation of Histone Arginine Methylation
    Mann, M.
    Cortez, V.
    Yang, B. W.
    Tekmal, R. R.
    Vadlamudi, R. K.
    CANCER RESEARCH, 2011, 71